⌘K
Loading ticker…
Gilead Sciences Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Gilead Sciences Inc (GILD) has a 3-month relative strength percentile of 30 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.8%, relative volume 2.16×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
30 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
GILD is in a stage 3 topping pattern, week 3. Currently in a 93-day base; basing ADR 2.4% (broad 2.5%). VCP detected: 3 contractions. RS line below base-start high. Distance from 50d / 200d: -1.9% / -1.4%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
GILD is held by 24 ETFs as of Mar 2026. Top owner: VTI at 0.28% weight, $5.5B notional. Top 3 carry $13.5B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.28% | $5.5B |
| VOOVanguard S&P 500 ETF | 0.31% | $4.4B |
| QQQInvesco QQQ Trust Series I | 0.98% | $3.6B |
| IVViShares Core S&P 500 ETF | 0.31% | $2.2B |
| SPYState Street SPDR S&P 500 ETF | 0.31% | $2.0B |
| VTVVanguard Value ETF | 0.71% | $1.6B |
| XLVState Street Health Care Select Sector SPDR ETF | 3.26% | $1.3B |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.31% | $364M |
| IWDiShares Russell 1000 Value ETF | 0.42% | $291M |
| DGRWWisdomTree U.S. Quality Dividend Growth Fund | 1.52% | $233M |
Showing 10 of 24 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GILD Jan avg: 3.82% median: 1.50% win: 50% σ: 8.77% n: 4 2022-04-12 → 2026-05-29 | GILD Feb avg: 2.65% median: 0.43% win: 50% σ: 11.32% n: 4 2022-04-12 → 2026-05-29 | GILD Mar avg: -0.95% median: -0.19% win: 50% σ: 4.22% n: 4 2022-04-12 → 2026-05-29 | GILD Apr avg: -5.41% median: -4.92% win: 0% σ: 3.67% n: 5 2022-04-12 → 2026-05-29 | GILD May avg: 1.50% median: 2.74% win: 60% σ: 5.84% n: 5 2022-04-12 → 2026-05-29 | GILD Jun avg: 0.74% median: 0.44% win: 75% σ: 4.69% n: 4 2022-04-12 → 2026-05-29 (current) | GILD Jul avg: 1.90% median: 0.04% win: 50% σ: 6.26% n: 4 2022-04-12 → 2026-05-29 | GILD Aug avg: 2.79% median: 2.23% win: 100% σ: 2.78% n: 4 2022-04-12 → 2026-05-29 | GILD Sep avg: -0.11% median: -1.88% win: 25% σ: 4.18% n: 4 2022-04-12 → 2026-05-29 | GILD Oct avg: 11.46% median: 6.93% win: 100% σ: 10.56% n: 4 2022-04-12 → 2026-05-29 | GILD Nov avg: 4.69% median: 4.64% win: 75% σ: 5.89% n: 4 2022-04-12 → 2026-05-29 | GILD Dec avg: 0.20% median: -1.24% win: 25% σ: 3.84% n: 4 2022-04-12 → 2026-05-29 |